Circulatory, chemical, and ventilatory response factors in Cheyne-Stokes respiration (CSR) were studied by experimental procedures and by mathematical analysis. Hemodynamic, ventilatory, and blood gas patterns in 16 patients with heart disease and CSR (group A) and 16 patients with congestive heart failure (CHF) without CSR (group B) were compared. CO2 and oxygen were administered to group A. The phenomena exhibited by patients with CSR were simulated by a mathematical model.
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identification of the relative importance of altered hemodynamic state, acid-base balance, and ventilatory response to CO2 in CSR. Four types of investigation are employed. These are: (1) description of hemodynamic variables in patients with congestive heart failure, with and without CSR; (2) examination of the acid-base equilibria and CO2 sensitivity in patients with congestive heart failure, with and without CSR; (3) observation of the time course of the effect of CO2 (and 02) on CSR; and (4) application of theoretical analysis of the respiratory control system so that the influence of chemical and hemodynamic variables can be assessed.
Methods Patient Selection and Treatment

A. Patients with Cheyne-Stokes Respiration
The 16 patients selected for study included all patients encountered over a 3-year period in whom CSR was observed and who would consent to the measurement of ventilation and blood gases. The average age was 68 years (range, 50 to 88). All patients presented with symptoms and signs referable to the cardiorespiratory system. Five had associated neurological disease. One was obese with alveolar hypoventilation; one had a small ventricular septal defect secondary to a myocardial infarction; one was mildly azotemic; and one had moderately severe irondeficiency anemia. Studies were carried out after optimal therapy for orthopnea, edema, and venous and pulmonary congestion. Therapy for congestive heart failure invariably included digitalis, dietary sodium restriction, and thiazide diuretics with potassium supplement and, at times, mercurial diuretics. Patients were free of edema; however, residual mild pulmonary congestion was not infrequent.
B. Control Group
Ventilatory and arterial blood gas measurements were incidental to diagnostic cardiac catheterization in 16 patients with heart disease characterized by pulmonary and systemic venous congestion and reduced cardiac output but without CSR. The mean age was 46 years (range, 22 to 64). The patients, selected in sequence, had received digitalis, dietary salt restriction, and thiazide diuretics with potassium supplements. These patients served as a control group in that therapy for congestive heart failure was similar to that in group A.
Procedure
Patients in the post-absorptive state and without premedication were placed in a supine position with head supported by one or two small pillows. Auditory and visual distractions were minimized in a dimly lighted room. After a 15-to 20-min rest period, a large bore mouthpiece connected to a Rudolf low resistance valve by short length flexible tubing was inserted and the nose gently clamped. Inspired gas could be altered without the patient's knowledge.
After a 4-to 6-min recording of periodic respiration while breathing room air, administration of a mixture of 2% CO2 in air was begun, usually at the end of a period of apnea, and continued for 4 to 10 min, whereupon room air ventilation was resumed. Ten to 15 min later the inspired gas was changed to 100% oxygen for 5 to 10 min with subsequent return to room air. An indwelling arterial needle allowed withdrawal of blood samples for analysis of gas tension and hydrogen-ion concentration (Instrumentation Laboratories Model 113) and oxygen saturation by gasometric (Van Slyke) and oximetric methods (Astrup) during apneic and hyperpneic periods throughout the study. WVhen tolerated, higher concentrations of CO2 in air, up to 5.11%, were administered.
Indicator-dilution curves were recorded via a densitometer sampling system (Waters Model 300) from the femoral artery employing venous or central circulatory injection of 10 to 15 mg of indocyanine green with an 8-to 12-ml saline flush. The Hamilton method was employed for estimation of cardiac output and mean circulation time. The lung to artery circulation time was estimated by subtracting arm to lung time (ether method) when the arm to artery method was employed. In three patients investigated by right heart catheterization in addition to the preceding procedure, direct estimation of lung to artery circulation time was carried out.
The expired gas was led to a wedge spirometer (Medical Science Electronics Model 170) through a spirometer recycler (Medical Science Electronics Model 176). The spirometer was recycled by manual control every 6 to 7 L during the expiratory pause or during inspiration. The recycling was accomplished in less than 1 sec and could not be appreciated by the subject. Gas constantly sampled from the mouthpiece at 100 to 200 ml/min passed through the microcuvette of a Beckman CO2 analyzer (Model LB-1). Pa02 was 89+± 2.0 in the patients with congestive heart failure but without CSR. Arterial CO2 tension varied during the ventilatory cycle from 33 mm Hg during the apneic period to 39.5 mm Hg during hyperpnea; the estimated mean was not significantly different from that seen in patients with congestive heart failure. Inhalation of CO2 caused a slight rise during the period of reduced ventilation and a slight fall during the hyperpneic phase. Oxygen effects were noted in seven of the 16 patients. This showed a somewhat greater increase in CO2 tension during the hyperpneic phase.
pH determinations indicated mild respiratory alkalosis. The highest pH values were observed during apnea and the lowest values during the hyperpneic phase. The degree of alkalosis was similar to that seen in congestive heart failure. Administration of CO2 to seven of the 16 did not induce any appreciable difference in the range of pH from that dur- The reduction in mean Paco2 and increased mean VE implies an abnormal chemoreceptor response. Periodic breathing precludes description of chemoreceptor by the usual CO2 response curves. Therefore, the chemoreceptor characteristics of CO2 were estimated by other means.
1. VE and PacO2 were related during CO2 inhalation when apnea was abolished in nine patients. Figure 3 The response to 02 was, however, variable and-for the present purposes-simulation will be limited to the room air and CO. response. The development of the method of simulation has been fully dealt with in the earlier publications and is briefly reviewed in the "Appendix." A diagram of the elements of the control system is shown in figure 4 .
The fig. 5A and B) . Brown and Plum13 reported on CSR in patients with heart disease who exhibited acid-base characteristics similar to those in our work. We agree that the threshold to CO2 is reduced; however, we observed reduced CO2 sensitivity rather than the increased sensitivity claimed by the work cited.
The reduced ventilatory response to CO2 may be related to the increased work of breathing for a given level of ventilation in the patients under study. Pauli and associates'9 suggested that reduced lung compliance was operative in patients with mitral stenosis who exhibited reduced ventilatory response to C02, since corrective surgery was followed by a more nearly normal CO2 response. The synergistic effect of lowered PaO2 during hyperpnea on room air (60 mm Hg) is absent with CO2 exposure. This factor, along with the increased work of breathing, may also explain the rapid attainment of maximal ventilatory response (less than that of normal subjects) in the patients reported here. Mild to severe alkalosis is again noted in all patients with congestive heart failure with and without CSR. However, the degree of alkalosis was variable. Previous work took note of this tendency toward alkalosis and suggested that the nonlinear effect of apnea and hyperpnea would result in mild respiratory alkalosis by a net increase in mean minute ventilation.6 Temporary periodic breathing may be observed in patients who suffer from metabolic acidosis and are rendered alkalotic by excessive bicarbonate administration. We have commented on the occurrence of recurrent tachyeardia with apnea in periodic breathing in alkalosis and have found CO2 administration to be of value. 20 The basis for the alkalotic state in many of the patients reported herein remains obscure; however, thiazide administration may be incriminated in some.
Circulation, Volume XXXVII, March 1968 Results of CO2 Breathing: Prototype and Model For many years, the effect of inhalation of low percentage of CO2 on the prevention of apnea has been known and its effect is rather uniform. Investigators have applied this method in their studies of periodic breathing since the early part of this century.'
Certain intuitive generalizations regarding the effect of CO2 may be made. The first is that, although CO2 could be expected to increase the mean value of arterial CO2 tension, and thereby to act as a respiratory stimulant, the rate of excretion of CO2 from the lungs (VA) (PACO2 -PIC02) is significantly decreased.
As a consequence, the first hyperpneic phase of periodic breathing after an increase in P'CO2 is associated with a reduced rate of CO2 excretion from the body. Therefore, the EFFECT OF CO2 ON VE, P002, Paco2
conditions which previously had allowed apnea, that is, a combination of Paco2 reduced below the threshold point and nearly normal Pa02, are prevented. These effects would first be expected one-half cycle length after a change in the inspired gas was made. This is well demonstrated in figure 1 in that, after institution of CO2 inhalation, the initial period of hyperpnea is unchanged. However, the subsequent hypopnea is less marked and apnea may be prevented or greatly abbreviated. One might summarize the expected effects on the control system as being twofold. The first would be a reduction in overall system gain, decreasing the amplitude of oscillation. The second would be an increased DC output level (ventilation). These would combine to produce an increased mean ventilation with reduced oscillation. information from normal subjects and patients with heart disease. Additional evidence for our conclusions lies in the ability to apply the model without modification to naturally occurring disorders, for example heart failure12 as well as experimental manipulations such as post-hyperventilation apnea,8, 9 response to altered CSF Po0215 and, in the present study, the effect of CO2 inhalation in periodic breathing. The successful application in disease conditions strengthened the conclusion that the mathematical model is efficient, unambiguous, and approaches the unique.
Circulation, Volume XXXVII, March 1968 Determinants of Periodic Respiration When the disorders of the cardiorespiratory system in all patients with congestive heart failure reported here are compared, certain similarities and differences appear significant. Reduction in cardiac output, alteration of the CO2 threshold and response and arterial pH and PaC02 are similar in the two groups.
Minor differences in Pa02 were noted; however, CSR was observed in the absence of hypoxemia.
The greater prolongation of circulation time (40 sec) in CSR provides the most striking difference between the groups. The cardiac index in group A was only slightly less than that in group B. The longer circu- The first would be related to the increased central blood volume in group A. A prolongation of the average value would result if patients with the largest central blood volume tended to have the lowest cardiac output. When the significantly longer circulation time in patients with CSR is considered along with the earlier report of oscillatory behavior in the model with a circulatory delay of greater than 25 sec,'2 the conclusion follows that significant prolongation of circulation time is requisite for periodic respiration in heart disease. When CSR is seen with shorter circulatory delays (and periods), increased neural excitability, anemia or hypoxemia, singly or in combination would, by increasing overall system gain, be implicated.
Appendix
The closed-loop system depicted in figure 4 will be represented by the 
